๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-Positive Chronic Hepatitis B

โœ Scribed by Lau, George K.K.; Piratvisuth, Teerha; Luo, Kang Xian; Marcellin, Patrick; Thongsawat, Satawat; Cooksley, Graham; Gane, Edward; Fried, Michael W.; Chow, Wan Cheng; Paik, Seung Woon; Chang, Wen Yu; Berg, Thomas; Flisiak, Robert; McCloud, Philip; Pluck, Nigel

Book ID
126188883
Publisher
Massachusetts Medical Society
Year
2005
Tongue
English
Weight
191 KB
Volume
352
Category
Article
ISSN
0096-6762

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

HBeAg and hepatitis B virus DNA as outco
HBeAg and hepatitis B virus DNA as outcome predictors during therapy with peginterferon alfa-2a for HBeAg-positive chronic hepatitis B
โœ Michael W. Fried; Teerha Piratvisuth; George K. K. Lau; Patrick Marcellin; Wan-C ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 414 KB ๐Ÿ‘ 2 views

The aims of this study were to evaluate the usefulness of quantitative hepatitis B e antigen (HBeAg) values for predicting HBeAg seroconversion in patients treated with peginterferon alfa-2a and to assess the dynamic changes in quantitative HBeAg during therapy, compared with conventional measures o

Long-term follow-up of peginterferon and
Long-term follow-up of peginterferon and lamivudine combination treatment in HBeAg-positive chronic hepatitis B
โœ Henry Lik-Yuen Chan; Alex Yui Hui; Vincent Wai-Sun Wong; Angel Mei-Ling Chim; Ma ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 141 KB ๐Ÿ‘ 2 views

We have previously demonstrated that combination peginterferon and lamivudine treatment has superior antiviral efficacy to lamivudine monotherapy in chronic hepatitis B. In this study, we investigated the long-term posttreatment virological response to this combination treatment. Sustained virologic